(Q43428539)

23 November 2017

title

Epidemiological changes in hepatitis B prevalence in an entire population after 20 years of the universal HBV vaccination programme (English)

1 reference

23 November 2017

1 reference

L P Shen

1

1 reference

23 November 2017

Y Zhang

2

1 reference

23 November 2017

F Wang

3

1 reference

23 November 2017

S Zhang

4

1 reference

23 November 2017

J Y Yang

5

1 reference

23 November 2017

K X Fang

6

1 reference

23 November 2017

T Yu

7

1 reference

23 November 2017

X Y Wang

8

1 reference

23 November 2017

W Y Zhang

9

1 reference

23 November 2017

S L Bi

10

1 reference

23 November 2017

publication date

15 December 2010

1 reference

Epidemiology and Infection

23 November 2017

published in

1 reference

23 November 2017

volume

139

1 reference

23 November 2017

issue

8

1 reference

23 November 2017

page(s)

1159-1165

1 reference

Long-term effectiveness of infancy low-dose hepatitis B vaccine immunization in Zhuang minority area in China

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Impact of hepatitis B immunization, Europe and worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Clinical practice: prevention of hepatitis B with the hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

The global impact of vaccination against hepatitis B: a historical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Implementing the birth dose of hepatitis B vaccine in rural Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

Sex distribution of Australia antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

7 January 2021

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

7 January 2021

Research on optimal immunization strategies for hepatitis B in different endemic areas in China

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

7 January 2021

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

7 January 2021

Long-term follow-up of hepatitis B vaccine in infants of carrier mothers

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

7 January 2021

What level of hepatitis B antibody is protective?

1 reference

https://api.crossref.org/works/10.1017%2FS0950268810002827

7 January 2021

10.1017/S0950268810002827

Identifiers

DOI

1 reference

23 November 2017

1 reference